Latest / Decera Clinical Education Oncology Podcast
Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing: Experts Answer Clinician Questions
In this episode, George D. Demetri, MD; Alexander Drilon, MD; and Pashtoon Kasi, MD, answer questions about NTRK fusion testing and TRK inhibitor therapy for patients with advanced solid tumors, with topics including:
Best practices in testing for NTRK fusions in solid tumors
Optimal use of approved TRK inhibitors
Key adverse events with TRK inhibitors and management strategies
Emerging next-generation TRK inhibitors and their potential use in managing resistance to first-generation agents
Presenters:
George D. Demetri, MD
Professor of Medicine
Harvard Medical School
Harvard University…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.